CT Simulators Market - Global Forecast to 2030
商品番号 : SMB-90465
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年11月 |
| ページ数 | 228 |
| 図表数 | 247 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
CTシミュレータ市場 – 技術（2D、3D/4Dシミュレーション）、製品タイプ（マルチスライス、シングルスライス）、用途（IGRT、3Dコンフォーマル放射線治療、密封小線源治療、SGRT、陽子線治療）、エンドユーザー（放射線治療センター、病院） – 2030年までの世界予測
世界の CT シミュレータ市場は、予測期間中に 4.6% の CAGR で成長し、2025 年の 5 億 9,810 万米ドルから 2030 年には 7 億 4,170 万米ドルに達すると予測されています。
CTシミュレータ市場は、技術の進歩、罹患率の上昇、そして医療インフラへの戦略的投資に牽引され、力強い成長を遂げています。これらの要因が相まって、CTシミュレーションの効率、精度、そして可用性が向上し、診断と治療の両面で患者アウトカムの向上につながっています。3D/4Dイメージング、リアルタイム機能、ポータブルソリューションといったCTシミュレーションの継続的なイノベーションは、診断精度と運用効率の向上に貢献しています。AIと機械学習の統合により、画像解析と治療計画がさらに強化され、自動異常検出、正確な解剖学的マッピング、そして個別化治療が可能になり、患者アウトカムとケアの質が向上します。
- 本レポートは、製品タイプ、技術、用途、エンドユーザー、地域に基づいてCTシミュレータ市場を調査しています。
- 本レポートは、市場の成長に影響を与える要因（推進要因、制約要因、機会、課題など）を分析しています。
- 本レポートは、利害関係者にとっての市場における機会と課題を評価し、市場リーダーの競争環境の詳細を提供しています。
- 本レポートは、マイクロ市場の成長傾向、見通し、そして世界のCTシミュレータ市場への貢献について調査しています。
- 本レポートは、5つの主要地域における市場セグメントの収益を予測しています。
本レポートは、市場への新規参入者と既存参入者の両方にとって価値ある情報を提供し、潜在的な投資機会を特定するための重要な情報を提供します。主要プレーヤーとマイナープレーヤーの両方を包括的に概観し、効果的なリスク分析と情報に基づいた投資判断を支援します。エンドユーザーと地域別に正確にセグメント化することで、ニッチな市場セグメントに関する詳細な洞察を提供します。さらに、主要なトレンド、成長ドライバー、課題、そして機会を浮き彫りにし、バランスの取れたアプローチ分析を通じて戦略的意思決定を支援します。
このレポートを通じて、読者は以下のパラメータについての洞察を得ることができます。
- CTシミュレーター市場の成長に関連する主な推進要因（画像誘導および適応型放射線治療（IGRT/ART）の採用拡大、寡分割照射および定位放射線治療（SBRT）への世界的な推進、がん発症率の上昇と診断用CTの利用増加）、制約要因（代替手段としてのAI主導型CBCTから合成CT（sCT）への変換における最近の進歩、診断用CTまたはPET/CTスキャンとの重複認識）、機会（AIとPCCTによる高性能シミュレーションの機会の解放、ハイブリッドCT-リニアックおよびCT-on-railsソリューションの使用）、課題（高い資本コスト）の分析。
- 製品開発／イノベーション：CTシミュレータ市場における今後の技術、研究開発活動、新製品・新サービスの投入に関する詳細な洞察。
- 市場開発：収益性の高い市場に関する包括的な情報 – 本レポートでは、様々な地域におけるCTシミュレータ市場を分析しています。
- 市場の多様化：CTシミュレータ市場における新製品、未開拓地域、最近の開発状況、投資に関する包括的な情報。
- 競合評価: Siemens Healthineers (ドイツ)、GE Healthcare (米国)、Philips Healthcare (オランダ)、キヤノンメディカルシステムズ株式会社 (日本)、バリアンメディカルシステムズ (米国)、Elekta (スイス)、富士フイルム株式会社 (米国)、Fluke Biomedical (米国)、Ziehm Imaging Gmbh (ドイツ) などの主要企業の市場シェア、製品提供、主要戦略の包括的な分析。
Report Description
The global CT simulators market is projected to reach USD 741.7 million by 2030, up from USD 598.1 million in 2025, at a CAGR of 4.6% during the forecast period.
The CT simulators market is experiencing strong growth driven by technological advancements, increasing disease rates, and strategic investments in healthcare infrastructure. These factors collectively enhance the efficiency, accuracy, and availability of CT simulation, resulting in improved patient outcomes in both diagnostic and therapeutic settings. Continuous innovation in CT simulation, including 3D/4D imaging, real-time capabilities, and portable solutions, has enhanced diagnostic accuracy and operational efficiency. The integration of AI and machine learning further enhances image analysis and treatment planning, enabling automated anomaly detection, precise anatomical mapping, and personalized therapy, thereby improving patient outcomes and care quality.
“Multi-slice CT simulators dominated the market in 2024.”
The multi-slice CT simulators segment contributes to the CT simulator market, driven by several key factors. Their superior imaging capabilities offer high-resolution visualization of anatomical structures, which is vital for accurate radiation therapy planning, ensuring precise tumor targeting while reducing exposure to surrounding healthy tissue. Advanced technology allows for faster scan times, increasing patient throughput and operational efficiency. Additionally, the growing prevalence of cancer and chronic diseases has boosted demand for precise diagnostic and treatment planning solutions. The increasing adoption of minimally invasive procedures, which rely on detailed imaging for accurate guidance, further strengthens the market position of multi-slice CT simulators.
“The independent radiotherapy segment held the largest share of the CT simulators market in 2024.”
Independent radiotherapy centers hold the largest share of the CT simulators market due to their increasing number, technology focus, and high equipment utilization. According to the International Atomic Energy Agency (IAEA) and WHO’s DIRAC database, over 60–65% of newly installed radiotherapy units worldwide are located in stand-alone or private cancer centers, especially across North America, Europe, and parts of the Asia Pacific. These centers heavily invest in dedicated imaging infrastructure, with each site typically needing at least one high-performance multi-slice CT simulator for treatment planning and quality assurance.
Independent radiotherapy centers mainly focus on cancer treatment workflows, where accurate imaging and simulation are essential for radiation therapy planning. Unlike hospitals, which can share diagnostic CT scanners among departments, radiotherapy centers need dedicated CT simulators optimized specifically for therapy planning—making adoption necessary rather than optional. These centers often manage a steady flow of oncology patients but do not have the complex departmental dependencies typical of hospitals. Therefore, they seek dedicated, high-throughput CT simulators that provide quick image acquisition, automated contouring, and seamless integration with Treatment Planning Systems (TPS) to reduce turnaround times.
“The Asia Pacific regional segment is expected to register the highest CAGR in the CT simulators market during the forecast period.”
The Asia-Pacific region is showing the fastest growth in the CT simulator market, driven by the rising prevalence of chronic conditions such as cancer, cardiovascular diseases, and respiratory disorders. This trend is significantly increasing the demand for advanced diagnostic and treatment planning technologies, including CT simulators. Ongoing technological innovation—such as the integration of artificial intelligence (AI), advanced 3D/4D imaging techniques, and low-dose CT scanning—is improving both the performance and accessibility of CT simulators throughout the region. Large investments in healthcare infrastructure, especially in emerging economies like India and China, are supporting the quick adoption of cutting-edge medical technologies. Additionally, growing public awareness about the importance of early disease detection is boosting the use of advanced imaging tools in both urban and rural healthcare settings. Together, these factors establish the Asia-Pacific region as the main driver of CT simulator market growth during the forecast period.
A breakdown of the primary participants referred to for this report is provided below:
- By Company: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
- By Designation: C-level Executives (35%), Director-level Executives (25%), and Others (40%)
- By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and the Middle East & Africa (5%)
Prominent players in the CT simulators market include Siemens Healthineers (Germany), GE Healthcare (US), Philips Healthcare (Netherlands), Canon Medical Systems Corporation (Japan), Varian Medical Systems (US), Elekta (Switzerland), Fujifilm Corporation (US), Fluke Biomedical (US), Ziehm Imaging Gmbh (Germany), among others.
Research Coverage
- The report studies the CT simulators market based on product type, technology, application, end user, and region
- The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth
- The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
- The report studies micro markets with respect to their growth trends, prospects, and contributions to the global CT simulators market
- The report forecasts the revenue of market segments with respect to five major regions
Key Benefits of Buying this Report
This report is valuable for both new and experienced players in the market, providing essential information to identify potential investment opportunities. It offers a comprehensive overview of both major and minor players, supporting effective risk analysis and informed investment decisions. The report includes precise segmentation by end users and geographic regions, giving detailed insights into niche market segments. Additionally, it highlights key trends, growth drivers, challenges, and opportunities, aiding strategic decision-making through a balanced approach analysis.
Through this report, readers get insightful views into the following parameters:
- Analysis of key drivers (Growing adoption of image-guided and adaptive radiotherapy (IGRT/ART), Global push toward hypofractionation and stereotactic body radiotherapy (SBRT), Rising cancer incidence and increasing diagnostic CT utilization), restraints (Recent advances in AI-driven CBCT-to-synthetic CT (sCT) conversions as replacement, Perceived overlap with diagnostic CT or PET/CT scans), opportunities (AI and PCCT unlocking high-performance simulation opportunities, Use of hybrid CT-linac and CT-on-rails solutions), challenges (High capital costs), relating to the growth of the CT simulators market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the CT simulators market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the CT simulators market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the CT simulators market
- Competitive Assessment: A comprehensive analysis of market share, product offerings, and leading strategies of major players, such as Siemens Healthineers (Germany), GE Healthcare (US), Philips Healthcare (Netherlands), Canon Medical Systems Corporation (Japan), Varian Medical Systems (US), Elekta (Switzerland), Fujifilm Corporation (US), Fluke Biomedical (US), Ziehm Imaging Gmbh (Germany).
Table of Contents
1 INTRODUCTION 24
1.1 STUDY OBJECTIVES 24
1.2 MARKET DEFINITION 24
1.3 STUDY SCOPE 25
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 25
1.3.2 INCLUSIONS & EXCLUSIONS 26
1.3.3 YEARS CONSIDERED 26
1.3.4 CURRENCY CONSIDERED 27
1.4 STAKEHOLDERS 27
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
2.1.1 SECONDARY RESEARCH 29
2.1.1.1 Key secondary sources 30
2.1.1.2 Key data from secondary sources 30
2.1.1.3 Objectives of secondary research 31
2.1.2 PRIMARY RESEARCH 31
2.1.2.1 Key primary sources 32
2.1.2.2 Key supply- and demand-side participants 32
2.1.2.3 Breakdown of primary interviews 33
2.1.2.4 Objectives of primary research 33
2.1.2.5 Key primary insights 34
2.2 MARKET SIZE ESTIMATION 34
2.2.1 BOTTOM-UP APPROACH 35
2.2.1.1 Company revenue estimation 36
2.2.1.2 Customer-based market estimation 36
2.2.1.3 Primary interviews 37
2.2.2 TOP-DOWN APPROACH 37
2.3 GROWTH RATE ASSUMPTIONS 39
2.4 DATA TRIANGULATION 41
2.5 STUDY ASSUMPTIONS 42
2.6 RESEARCH LIMITATIONS 42
2.7 RISK ANALYSIS 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 48
4.1 CT SIMULATORS MARKET OVERVIEW 48
4.2 ASIA PACIFIC: GROWTH OPPORTUNITIES, BY END USER AND COUNTRY 49
4.3 CT SIMULATORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 50
5 MARKET OVERVIEW 51
5.1 INTRODUCTION 51
5.2 MARKET DYNAMICS 51
5.2.1 DRIVERS 52
5.2.1.1 Growing adoption of image-guided and adaptive radiotherapy (IGRT/ART) 52
5.2.1.2 Global push toward hypofractionation and stereotactic body radiotherapy (SBRT) 53
5.2.1.3 Rising cancer incidence and increasing diagnostic CT utilization 53
5.2.2 RESTRAINTS 53
5.2.2.1 Recent advances in AI-driven CBCT-to-synthetic CT (sCT) conversions as replacement 53
5.2.2.2 Perceived overlap with diagnostic CT or PET/CT scans 54
5.2.3 OPPORTUNITIES 54
5.2.3.1 AI and PCCT unlocking high-performance simulation opportunities 54
5.2.3.2 Use of hybrid CT-linac and CT-on-rails solutions 54
5.2.4 CHALLENGES 54
5.2.4.1 High capital costs 54
5.3 UNMET NEEDS & WHITE SPACES 55
5.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 55
5.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 56
6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS,
AND AI ADOPTION 58
6.1 TECHNOLOGY ANALYSIS 58
6.1.1 KEY TECHNOLOGIES 58
6.1.1.1 Radiotherapy planning software/Value-based software 58
6.1.1.2 Flat-table couch & laser positioning 58
6.1.1.3 4D CT & motion management 58
6.1.2 COMPLEMENTARY TECHNOLOGIES 58
6.1.2.1 Linear accelerators (LINACs) 58
6.1.2.2 Dosimetry tools 58
6.1.2.3 Treatment verification systems 59
6.1.3 ADJACENT TECHNOLOGIES 59
6.1.3.1 MRI simulators 59
6.1.3.2 Cone-beam CT (CBCT) in LINACs 59
6.1.3.3 Photon and proton therapy delivery systems 59
6.2 PATENT ANALYSIS 59
6.2.1 INNOVATIONS AND PATENT REGISTRATIONS 61
6.3 FUTURE APPLICATIONS 61
6.4 IMPACT OF AI/GEN AI ON CT SIMULATORS MARKET 62
6.4.1 TOP USE CASES AND MARKET POTENTIAL 62
6.4.2 AI USE CASES 63
6.4.3 BEST PRACTICES IN CT SIMULATION 63
6.4.4 CASE STUDIES OF AI IMPLMENTATION 63
6.4.5 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 64
6.4.6 CLIENT’S READINESS TO ADOPT GENERATIVE AI 64
6.5 SUCCESS STORIES & REAL-WORLD APPLICATIONS 65
7 SUSTAINABILITY & REGULATORY LANDSCAPE 66
7.1 REGIONAL REGULATIONS & COMPLIANCE 66
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66
7.1.2 REGULATORY FRAMEWORK 69
7.1.2.1 North America 69
7.1.2.1.1 US 69
7.1.2.1.2 Canada 70
7.1.2.2 Europe 70
7.1.2.2.1 UK 70
7.1.2.2.2 Germany 70
7.1.2.2.3 France 70
7.1.2.2.4 Italy 70
7.1.2.2.5 Spain 71
7.1.2.3 Asia Pacific 71
7.1.2.3.1 Japan 71
7.1.2.3.2 China 71
7.1.2.3.3 India 71
7.1.2.4 Latin America 72
7.1.2.4.1 Brazil 72
7.1.2.4.2 Mexico 72
7.1.2.5 Middle East & Africa 72
7.1.2.5.1 UAE 72
7.1.2.5.2 South Africa 73
7.1.3 CERTIFICATIONS, LABELLING, AND ECO-STANDARDS 73
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 75
8.1 KEY STAKEHOLDERS & BUYING EVALUATION CRITERIA 75
8.1.1 KEY STAKEHOLDERS IN BUYING PROCESS 75
8.1.2 KEY BUYING CRITERIA 76
8.2 DECISION-MAKING PROCESS 76
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 77
8.4 UNMET NEEDS FROM END USERS 77
8.4.1 UNMET NEEDS FROM END USERS 78
9 INDUSTRY TREND 79
9.1 PORTER’S FIVE FORCES ANALYSIS 79
9.1.1 THREAT OF NEW ENTRANTS 80
9.1.2 THREAT OF SUBSTITUTES 80
9.1.3 BARGAINING POWER OF SUPPLIERS 80
9.1.4 BARGAINING POWER OF BUYERS 80
9.1.5 INTENSITY OF COMPETITIVE RIVALRY 80
9.2 MACROECONOMIC INDICATORS 81
9.2.1 INTRODUCTION 81
9.2.2 HEALTHCARE EXPENDITURE & INFRASTRUCTURE OUTLOOK 81
9.2.3 TRENDS IN GLOBAL CT INDUSTRY 83
9.3 VALUE CHAIN ANALYSIS 84
9.3.1 RESEARCH & DEVELOPMENT 84
9.3.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING 84
9.3.3 DISTRIBUTION AND MARKETING & SALES 85
9.3.4 AFTER-SALES SERVICES 85
9.4 SUPPLY CHAIN ANALYSIS 85
9.4.1 PROMINENT COMPANIES 85
9.4.2 SMALL & MEDIUM-SIZED ENTERPRISES 85
9.4.3 END USERS 86
9.5 ECOSYSTEM ANALYSIS 86
9.5.1 ROLE IN ECOSYSTEM 87
9.6 PRICING ANALYSIS 87
9.6.1 AVERAGE SELLING PRICE TREND OF CT SIMULATORS, BY KEY PLAYER,
2022–2024 88
9.6.2 AVERAGE SELLING PRICE TREND OF CT SIMULATORS, BY REGION,
2022–2024 89
9.7 TRADE ANALYSIS 90
9.7.1 IMPORT DATA FOR HS CODE 9022.12 90
9.7.2 EXPORT DATA FOR HS CODE 9022.12 91
9.8 KEY CONFERENCES & EVENTS, 2025–2026 92
9.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 93
9.10 INVESTMENT & FUNDING SCENARIO 93
9.11 CASE STUDY ANALYSIS 95
9.11.1 SEAMLESS WORKFLOW INTEGRATION BY SIEMENS HEALTHINEERS (VARIAN) TO STRENGTHEN CT SIMULATORS MARKET POSITION 95
9.11.2 INNOVATION BY GE HEALTHCARE TO ENHANCE CT SIMULATION EFFICIENCY AND PRECISION 95
9.11.3 PHILIPS BIG BORE CT TO EXPAND GLOBAL ADOPTION IN RADIOTHERAPY SIMULATION 96
9.12 IMPACT OF 2025 US TARIFF ON CT SIMULATORS MARKET 96
9.12.1 INTRODUCTION 96
9.12.2 KEY TARIFF RATES 96
9.12.3 PRICE IMPACT ANALYSIS 97
9.12.4 IMPACT ON COUNTRIES/REGIONS 97
9.12.4.1 North America 97
9.12.4.1.1 US 97
9.12.4.2 Europe 97
9.12.4.3 Asia Pacific 97
9.12.5 IMPACT ON END-USE INDUSTRIES 97
10 CT SIMULATORS MARKET, BY TECHNOLOGY 99
10.1 INTRODUCTION 100
10.2 2D/3D CT SIMULATION TECHNOLOGY 100
10.2.1 CONVENTIONAL NEEDS AND SIZABLE DEMAND IN LOW-RESOURCE SETTINGS TO DRIVE MARKET DEMAND 100
10.3 3D/4D CT SIMULATION TECHNOLOGY 101
10.3.1 HIGH THROUGHPUT ABILITY AND EFFICIENCY TO PROPEL MARKET GROWTH 101
11 CT SIMULATORS MARKET, BY PRODUCT TYPE 103
11.1 INTRODUCTION 104
11.2 SINGLE-SLICE CT SIMULATORS 106
11.2.1 LOW-VOLUME APPLICATIONS AND COST-EFFECTIVENESS TO MAINTAIN STABLE DEMAND 106
11.3 MULTI-SLICE CT SIMULATORS 108
11.3.1 HIGH THROUGHPUT ABILITY AND EFFICIENCY TO FUEL MARKET DEMAND 108
12 CT SIMULATORS MARKET, BY APPLICATION 112
12.1 INTRODUCTION 113
12.2 IMAGE-GUIDED RADIATION THERAPY 113
12.2.1 HIGH-QUALITY CT SIMULATION TO NEED IGRT WORKFLOW FOR DRIVING DEMAND 113
12.3 3D CONFORMAL RADIATION THERAPY 114
12.3.1 CT SIMULATION TO PROVIDE VOLUMETRIC DATASETS FOR CONFORMAL BEAM SHAPING IN 3D CRT 114
12.4 BRACHYTHERAPY 115
12.4.1 OAR DELINEATION AND ACCURATE APPLICATOR VERIFICATION TO PROPEL DEMAND 115
12.5 ADAPTIVE RADIOTHERAPY/SURFACE-GUIDED RADIOTHERAPY 116
12.5.1 RISING ADOPTION OF CT SIMULATORS IN ADAPTIVE RADIOTHERAPY TO BOOST WORKFLOW PRECISION AND CLINICAL EFFICIENCY 116
12.6 PROTON THERAPY 117
12.6.1 CT SIMULATORS TO PROVIDE ESSENTIAL IMAGING SUPPORT FOR ACCURATE PROTON THERAPY PLANNING 117
12.7 OTHER APPLICATIONS 118
13 CT SIMULATORS MARKET, BY END USER 120
13.1 INTRODUCTION 121
13.2 INDEPENDENT RADIOTHERAPY CENTERS 121
13.2.1 GROWING INCIDENCE OF CANCER GLOBALLY TO PROPEL DEMAND FOR ADVANCED DIAGNOSTIC AND PLANNING TOOLS 121
13.3 HOSPITALS 122
13.3.1 RISING TREND OF INTEGRATED ONCOLOGY CARE SERVICES TO SUPPORT MARKET GROWTH 122
13.4 OTHER END USERS 123
14 CT SIMULATORS MARKET, BY REGION 124
14.1 INTRODUCTION 125
14.2 NORTH AMERICA 125
14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 125
14.2.2 US 128
14.2.2.1 US to dominate North American CT simulators market during study period 128
14.2.3 CANADA 129
14.2.3.1 Increased demand for advanced imaging technologies to support market growth 129
14.3 EUROPE 130
14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 130
14.3.2 GERMANY 133
14.3.2.1 Aging population with high burden of chronic diseases to augment market growth 133
14.3.3 UK 134
14.3.3.1 Need for faster cancer treatment and better image quality at lower radiation doses to support market growth 134
14.3.4 ITALY 134
14.3.4.1 Increasing investments in CT simulators to drive market 134
14.3.5 SPAIN 135
14.3.5.1 Increasing demand for integration of CT simulation solutions in radiation oncology department to propel market 135
14.3.6 REST OF EUROPE 136
14.4 ASIA PACIFIC 136
14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 136
14.4.2 JAPAN 139
14.4.2.1 Increase in adoption of high-precision radiotherapy protocols to fuel market 139
14.4.3 CHINA 140
14.4.3.1 Expanding radiotherapy capacity across hospitals and cancer centers to aid market growth 140
14.4.4 INDIA 141
14.4.4.1 Improvements in healthcare infrastructure and rising incidence of cancer to boost market growth 141
14.4.5 SOUTH KOREA 142
14.4.5.1 Growing radiotherapy utilization to support market growth 142
14.4.6 AUSTRALIA 142
14.4.6.1 Expanding radiotherapy utilization to propel market growth 142
14.4.7 REST OF ASIA PACIFIC 143
14.5 LATIN AMERICA 144
14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 144
14.5.2 BRAZIL 147
14.5.2.1 Collaborative programs and partnerships to expand access to radiotherapy technologies and boost market 147
14.5.3 MEXICO 148
14.5.3.1 Rising demand for radiotherapy planning to promote market growth 148
14.5.4 REST OF LATIN AMERICA 149
14.6 MIDDLE EAST & AFRICA 149
14.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 150
14.6.2 GCC COUNTRIES 152
14.6.2.1 Need for advanced cancer treatment to spur market growth 152
14.6.3 REST OF MIDDLE EAST & AFRICA 153
15 COMPETITIVE LANDSCAPE 154
15.1 INTRODUCTION 154
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 154
15.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
CT SIMULATORS MARKET 154
15.3 REVENUE ANALYSIS, 2020–2024 156
15.4 MARKET SHARE ANALYSIS, 2024 157
15.4.1 MARKET RANKING OF KEY PLAYERS 159
15.5 COMPANY VALUATION & FINANCIAL METRICS 159
15.5.1 FINANCIAL METRICS 159
15.5.2 COMPANY VALUATION 159
15.6 BRAND/PRODUCT COMPARISON 161
15.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 162
15.7.1 STARS 162
15.7.2 PERVASIVE PLAYERS 162
15.7.3 EMERGING LEADERS 162
15.7.4 PARTICIPANTS 162
15.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 164
15.7.5.1 Company footprint 164
15.7.5.2 Region footprint 165
15.7.5.3 Product type footprint 166
15.7.5.4 Technology footprint 166
15.7.5.5 Application footprint 167
15.7.5.6 End-user footprint 168
15.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 168
15.8.1 PROGRESSIVE COMPANIES 168
15.8.2 RESPONSIVE COMPANIES 168
15.8.3 DYNAMIC COMPANIES 169
15.8.4 STARTING BLOCKS 169
15.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2024 170
15.8.5.1 Detailed list of key startups/SMEs 170
15.8.5.2 Competitive benchmarking of key startups/SMEs 171
15.9 COMPETITIVE SCENARIO 172
15.9.1 PRODUCT LAUNCHES 172
15.9.2 DEALS 172
15.9.3 EXPANSIONS 173
16 COMPANY PROFILES 175
16.1 KEY PLAYERS 175
16.1.1 SIEMENS HEALTHINEERS AG 175
16.1.1.1 Business overview 175
16.1.1.2 Products offered 176
16.1.1.3 Recent developments 177
16.1.1.3.1 Product launches 177
16.1.1.3.2 Deals 177
16.1.1.3.3 Expansions 178
16.1.1.3.4 Other developments 178
16.1.1.4 MnM view 179
16.1.1.4.1 Right to win 179
16.1.1.4.2 Strategic choices 179
16.1.1.4.3 Weaknesses & competitive threats 179
16.1.2 PHILIPS HEALTHCARE 180
16.1.2.1 Business overview 180
16.1.2.2 Products offered 181
16.1.2.3 Recent developments 182
16.1.2.3.1 Product launches 182
16.1.2.3.2 Expansions 182
16.1.2.4 MnM view 182
16.1.2.4.1 Right to win 182
16.1.2.4.2 Strategic choices 182
16.1.2.4.3 Weaknesses & competitive threats 183
16.1.3 GE HEALTHCARE 184
16.1.3.1 Business overview 184
16.1.3.2 Products offered 185
16.1.3.3 Recent developments 186
16.1.3.3.1 Product launches 186
16.1.3.3.2 Deals 186
16.1.3.3.3 Expansions 187
16.1.3.4 MnM view 187
16.1.3.4.1 Right to win 187
16.1.3.4.2 Strategic choices 187
16.1.3.4.3 Weaknesses & competitive threats 187
16.1.4 CANON MEDICAL SYSTEMS CORPORATION 188
16.1.4.1 Business overview 188
16.1.4.2 Products offered 189
16.1.4.3 Recent developments 190
16.1.4.3.1 Product launches 190
16.1.4.3.2 Deals 190
16.1.4.3.3 Expansions 191
16.1.4.4 MnM view 191
16.1.4.4.1 Right to win 191
16.1.4.4.2 Strategic choices 191
16.1.4.4.3 Weaknesses & competitive threats 191
16.1.5 ELEKTA 192
16.1.5.1 Business overview 192
16.1.5.2 Products offered 193
16.1.5.3 Recent developments 194
16.1.5.3.1 Product launches 194
16.1.5.3.2 Deals 194
16.1.5.3.3 Expansions 194
16.1.5.4 MnM view 195
16.1.5.4.1 Right to win 195
16.1.5.4.2 Strategic choices 195
16.1.5.4.3 Weaknesses & competitive threats 195
16.1.6 FUJIFILM HEALTHCARE 196
16.1.6.1 Business overview 196
16.1.6.2 Products offered 197
16.1.6.3 Recent developments 198
16.1.6.3.1 Deals 198
16.1.7 ZIEHM IMAGING GMBH 199
16.1.7.1 Business overview 199
16.1.7.2 Products offered 199
16.1.7.3 Recent developments 200
16.1.7.3.1 Product launches & approvals 200
16.1.7.3.2 Deals 200
16.1.8 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. 201
16.1.8.1 Business overview 201
16.1.8.2 Products offered 202
16.1.8.3 Recent developments 202
16.1.8.3.1 Deals 202
16.1.9 NEUSOFT MEDICAL SYSTEMS CO., LTD. 203
16.1.9.1 Business overview 203
16.1.9.2 Products offered 203
16.1.9.3 Recent developments 204
16.1.9.3.1 Product approvals 204
16.1.9.3.2 Deals 204
16.1.10 HITACHI HIGH-TECH CORPORATION 205
16.1.10.1 Business overview 205
16.1.10.2 Products offered 206
16.1.10.3 Recent developments 207
16.1.10.3.1 Other developments 207
16.1.11 SHINVA MEDICAL INSTRUMENT CO., LTD. 208
16.1.11.1 Business overview 208
16.1.11.2 Products offered 209
16.1.12 ACCURAY INCORPORATED 210
16.1.12.1 Business overview 210
16.1.12.2 Products offered 211
16.2 OTHER PLAYERS 212
16.2.1 DMS HEALTH 212
16.2.2 NORTH STAR IMAGING INC. 213
16.2.3 FLUKE BIOMEDICAL 213
16.2.4 PRIZMED IMAGING 214
16.2.5 KONING HEALTH 214
16.2.6 PLANMECA OY 215
16.2.7 PINSENG HEALTHCARE 215
16.2.8 SCANLAB 216
16.2.9 ARINETA LTD. 216
16.2.10 RYOEI 217
16.2.11 BRAINLAB SE 217
16.2.12 RADIOLOGY ONCOLOGY SYSTEMS 218
16.2.13 BLOCK IMAGING, INC. 218
17 APPENDIX 219
17.1 DISCUSSION GUIDE 219
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 224
17.3 CUSTOMIZATION OPTIONS 226
17.4 RELATED REPORTS 226
17.5 AUTHOR DETAILS 227
LIST OF TABLES
TABLE 1 CT SIMULATORS MARKET: INCLUSIONS & EXCLUSIONS 26
TABLE 2 CT SIMULATORS MARKET: STUDY ASSUMPTIONS 42
TABLE 3 CT SIMULATORS MARKET: RISK ANALYSIS 42
TABLE 4 CT SIMULATORS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 52
TABLE 5 CT SIMULATORS MARKET: UNMET NEEDS & WHITE SPACES 55
TABLE 6 STRATEGIC MOVES BY TIER 1, TIER 2, AND TIER 3 PLAYERS IN
CT SIMULATORS MARKET 56
TABLE 7 CT SIMULATORS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2024 61
TABLE 8 KEY COMPANIES IMPLEMENTING AI/GEN AI IN CT SIMULATORS MARKET 64
TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 66
TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 66
TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 67
TABLE 12 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 68
TABLE 13 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANISATIONS 69
TABLE 14 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF CT SIMULATORS,
BY PRODUCT TYPE 75
TABLE 15 KEY BUYING CRITERIA OF CT SIMULATORS, BY END USER 76
TABLE 16 UNMET NEED ANALYSIS IN CT SIMULATORS MARKET 77
TABLE 17 CT SIMULATORS MARKET: PORTER’S FIVE FORCES 79
TABLE 18 MACROECONOMIC INDICATORS FOR NORTH AMERICA 82
TABLE 19 MACROECONOMIC INDICATORS FOR EUROPE 82
TABLE 20 MACROECONOMIC INDICATORS FOR ASIA PACIFIC 82
TABLE 21 MACROECONOMIC INDICATORS FOR LATIN AMERICA 83
TABLE 22 MACROECONOMIC INDICATORS FOR MIDDLE EAST & AFRICA 83
TABLE 23 CT SIMULATORS MARKET: ROLE IN ECOSYSTEM 87
TABLE 24 KEY PARAMETERS IMPACTING PRICES FOR CT SIMULATORS 87
TABLE 25 AVERAGE SELLING PRICE TREND OF CT SIMULATORS, BY KEY PLAYER,
2022–2024 (USD) 88
TABLE 26 AVERAGE SELLING PRICE TREND OF CT SIMULATORS, BY REGION,
2022–2024 (USD) 89
TABLE 27 IMPORT SCENARIO FOR HS CODE 9022.12 BY COUNTRY,
2020–2024 (USD THOUSAND) 90
TABLE 28 EXPORT SCENARIO FOR HS CODE 9022.12, BY COUNTRY,
2020–2024 (USD THOUSAND) 91
TABLE 29 CT SIMULATORS MARKET: KEY CONFERENCES & EVENTS,
JANUARY 2025–DECEMBER 2026 92
TABLE 30 CASE STUDY 1: SEAMLESS WORKFLOW INTEGRATION BY SIEMENS HEALTHINEERS (VARIAN) TO STRENGTHEN CT SIMULATORS MARKET POSITION 95
TABLE 31 CASE STUDY 2: INNOVATION BY GE HEALTHCARE TO ENHANCE CT SIMULATION EFFICIENCY AND PRECISION 95
TABLE 32 CASE STUDY 3: PHILIPS BIG BORE CT TO EXPAND GLOBAL ADOPTION IN RADIOTHERAPY SIMULATION 96
TABLE 33 KEY TARIFF RATES IN CT SIMULATORS MARKET, 2025 96
TABLE 34 CT SIMULATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 100
TABLE 35 CT SIMULATORS MARKET FOR 2D/3D SIMULATION TECHNOLOGY, BY REGION, 2023–2030 (USD MILLION) 101
TABLE 36 CT SIMULATORS MARKET FOR 3D/4D SIMULATION TECHNOLOGY, BY REGION, 2023–2030 (USD MILLION) 102
TABLE 37 NUMBER OF UNITS SOLD IN NORTH AMERICAN CT SIMULATORS MARKET, 2024 104
TABLE 38 NUMBER OF UNITS SOLD IN EUROPEAN CT SIMULATORS MARKET, 2024 104
TABLE 39 NUMBER OF UNITS SOLD IN ASIA PACIFIC CT SIMULATORS MARKET, 2024 105
TABLE 40 NUMBER OF UNITS SOLD IN LATIN AMERICAN AND MIDDLE EASTERN & AFRICAN CT SIMULATORS MARKET, 2024 105
TABLE 41 CT SIMULATORS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 105
TABLE 42 SINGLE-SLICE CT SIMULATORS MARKET, BY REGION, 2023–2030 (USD MILLION) 106
TABLE 43 NORTH AMERICA: SINGLE-SLICE CT SIMULATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 106
TABLE 44 EUROPE: SINGLE-SLICE CT SIMULATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 107
TABLE 45 ASIA-PACIFIC: SINGLE-SLICE CT SIMULATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 107
TABLE 46 LATIN AMERICA: SINGLE-SLICE CT SIMULATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 108
TABLE 47 MIDDLE EAST & AFRICA: SINGLE-SLICE CT SIMULATORS MARKET, BY REGION, 2023–2030 (USD MILLION) 108
TABLE 48 MULTI-SLICE CT SIMULATORS MARKET, BY REGION, 2023–2030 (USD MILLION) 109
TABLE 49 NORTH AMERICA: MULTI-SLICE CT SIMULATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 109
TABLE 50 EUROPE: MULTI-SLICE CT SIMULATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 110
TABLE 51 ASIA PACIFIC: MULTI-SLICE CT SIMULATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 110
TABLE 52 LATIN AMERICA: MULTI-SLICE CT SIMULATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 111
TABLE 53 MIDDLE EAST & AFRICA: CT SIMULATORS MARKET FOR MULTI-SLICE CT SIMULATORS, BY REGION, 2023–2030 (USD MILLION) 111
TABLE 54 CT SIMULATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 113
TABLE 55 CT SIMULATORS MARKET FOR IMAGE-GUIDED RADIATION THERAPY, BY REGION, 2023–2030 (USD MILLION) 114
TABLE 56 CT SIMULATORS MARKET FOR 3D CONFORMAL RADIATION THERAPY, BY REGION, 2023–2030 (USD MILLION) 115
TABLE 57 CT SIMULATORS MARKET FOR BRACHYTHERAPY, BY REGION,
2023–2030 (USD MILLION) 116
TABLE 58 CT SIMULATORS MARKET FOR ADAPTIVE RADIOTHERAPY/SURFACE-GUIDED RADIOTHERAPY, BY REGION, 2023–2030 (USD MILLION) 117
TABLE 59 CT SIMULATORS MARKET FOR PROTON THERAPY, BY REGION,
2023–2030 (USD MILLION) 118
TABLE 60 CT SIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION,
2023–2030 (USD MILLION) 119
TABLE 61 CT SIMULATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 121
TABLE 62 CT SIMULATORS MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS,
BY REGION, 2023–2030 (USD MILLION) 122
TABLE 63 CT SIMULATORS MARKET FOR HOSPITALS, BY REGION,
2023–2030 (USD MILLION) 123
TABLE 64 CT SIMULATORS MARKET FOR OTHER END USERS, BY REGION,
2023–2030 (USD MILLION) 123
TABLE 65 CT SIMULATORS MARKET, BY REGION, 2023–2030 (USD MILLION) 125
TABLE 66 NORTH AMERICA: KEY MACROINDICATORS 126
TABLE 67 NORTH AMERICA: CT SIMULATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 127
TABLE 68 NORTH AMERICA: CT SIMULATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 127
TABLE 69 NORTH AMERICA: CT SCANNERS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 127
TABLE 70 NORTH AMERICA: CT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 128
TABLE 71 NORTH AMERICA: CT SIMULATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 128
TABLE 72 US: CT SIMULATORS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 129
TABLE 73 CANADA: CT SIMULATORS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 130
TABLE 74 EUROPE: KEY MACROINDICATORS 131
TABLE 75 EUROPE: CT SIMULATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 131
TABLE 76 EUROPE: CT SIMULATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 132
TABLE 77 EUROPE: CT SCANNERS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 132
TABLE 78 EUROPE: CT SIMULATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 132
TABLE 79 EUROPE: CT SIMULATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 133
TABLE 80 GERMANY: CT SIMULATORS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 133
TABLE 81 UK: CT SIMULATORS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 134
TABLE 82 ITALY: CT SIMULATORS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 135
TABLE 83 SPAIN: CT SIMULATORS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 135
TABLE 84 REST OF EUROPE: CT SIMULATORS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 136
TABLE 85 ASIA PACIFIC: KEY MACROINDICATORS 137
TABLE 86 ASIA PACIFIC: CT SIMULATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138
TABLE 87 ASIA PACIFIC: CT SIMULATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 138
TABLE 88 ASIA PACIFIC: CT SCANNERS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 138
TABLE 89 ASIA PACIFIC: CT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 139
TABLE 90 ASIA PACIFIC: CT SIMULATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 139
TABLE 91 JAPAN: CT SIMULATORS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 140
TABLE 92 CHINA: CT SIMULATORS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 141
TABLE 93 INDIA: CT SIMULATORS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 142
TABLE 94 SOUTH KOREA: CT SIMULATORS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 142
TABLE 95 AUSTRALIA: CT SIMULATORS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 143
TABLE 96 REST OF ASIA PACIFIC: CT SIMULATORS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 144
TABLE 97 LATIN AMERICA: KEY MACROINDICATORS 145
TABLE 98 LATIN AMERICA: CT SIMULATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 145
TABLE 99 LATIN AMERICA: CT SIMULATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 145
TABLE 100 LATIN AMERICA: CT SCANNERS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 146
TABLE 101 LATIN AMERICA: CT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 146
TABLE 102 LATIN AMERICA: CT SIMULATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 147
TABLE 103 BRAZIL: CT SIMULATORS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 148
TABLE 104 MEXICO: CT SIMULATORS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 148
TABLE 105 REST OF LATIN AMERICA: CT SIMULATORS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 149
TABLE 106 MIDDLE EAST & AFRICA: KEY MACROINDICATORS 150
TABLE 107 MIDDLE EAST & AFRICA: CT SIMULATORS MARKET, BY REGION,
2023–2030 (USD MILLION) 150
TABLE 108 MIDDLE EAST & AFRICA: CT SIMULATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 151
TABLE 109 MIDDLE EAST & AFRICA: CT SCANNERS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 151
TABLE 110 MIDDLE EAST & AFRICA: CT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 152
TABLE 111 MIDDLE EAST & AFRICA: CT SIMULATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 152
TABLE 112 GCC COUNTRIES: CT SIMULATORS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 153
TABLE 113 REST OF MIDDLE EAST & AFRICA: CT SIMULATORS MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 153
TABLE 114 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CT SIMULATORS MARKET, 2022–2025 154
TABLE 115 CT SIMULATORS MARKET: DEGREE OF COMPETITION 157
TABLE 116 CT SIMULATORS MARKET: REGION FOOTPRINT 165
TABLE 117 CT SIMULATORS MARKET: PRODUCT TYPE FOOTPRINT 166
TABLE 118 CT SIMULATORS MARKET: TECHNOLOGY FOOTPRINT 166
TABLE 119 CT SIMULATORS MARKET: APPLICATION FOOTPRINT 167
TABLE 120 CT SIMULATORS MARKET: END-USER FOOTPRINT 168
TABLE 121 CT SIMULATORS MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 170
TABLE 122 CT SIMULATORS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY PRODUCT TYPE AND REGION 171
TABLE 123 CT SIMULATORS MARKET: PRODUCT LAUNCHES,
JANUARY 2022–SEPTEMBER 2025 172
TABLE 124 CT SIMULATORS MARKET: DEALS, JANUARY 2022–SEPTEMBER 2025 172
TABLE 125 CT SIMULATORS MARKET: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 173
TABLE 126 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 175
TABLE 127 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 176
TABLE 128 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES,
JANUARY 2022–SEPTEMBER 2025 177
TABLE 129 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022–SEPTEMBER 2025 177
TABLE 130 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 178
TABLE 131 SIEMENS HEALTHINEERS AG: OTHER DEVELOPMENTS, JANUARY 2022–SEPTEMBER 2025 178
TABLE 132 PHILIPS HEALTHCARE: COMPANY OVERVIEW 180
TABLE 133 PHILIPS HEALTHCARE: PRODUCTS OFFERED 181
TABLE 134 PHILIPS HEALTHCARE: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 182
TABLE 135 PHILIPS HEALTHCARE: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 182
TABLE 136 GE HEALTHCARE: COMPANY OVERVIEW 184
TABLE 137 GE HEALTHCARE: PRODUCTS OFFERED 185
TABLE 138 GE HEALTHCARE: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 186
TABLE 139 GE HEALTHCARE: DEALS, JANUARY 2022–SEPTEMBER 2025 186
TABLE 140 GE HEALTHCARE: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 187
TABLE 141 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW 188
TABLE 142 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED 189
TABLE 143 CANON MEDICAL SYSTEMS CORPORATION: PRODUCT LAUNCHES,
JANUARY 2022–SEPTEMBER 2025 190
TABLE 144 CANON MEDICAL SYSTEMS CORPORATION: DEALS,
JANUARY 2022–SEPTEMBER 2025 190
TABLE 145 CANON MEDICAL SYSTEMS CORPORATION: EXPANSIONS,
JANUARY 2022–SEPTEMBER 2025 191
TABLE 146 ELEKTA: COMPANY OVERVIEW 192
TABLE 147 ELEKTA: PRODUCTS OFFERED 193
TABLE 148 ELEKTA: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 194
TABLE 149 ELEKTA: DEALS, JANUARY 2022–SEPTEMBER 2025 194
TABLE 150 ELEKTA: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 194
TABLE 151 FUJIFILM HEALTHCARE: COMPANY OVERVIEW 196
TABLE 152 FUJIFILM HEALTHCARE: PRODUCTS OFFERED 197
TABLE 153 FUJIFILM CORPORATION: DEALS, JANUARY 2022–SEPTEMBER 2025 198
TABLE 154 ZIEHM IMAGING GMBH: COMPANY OVERVIEW 199
TABLE 155 ZIEHN IMAGING GMBH: PRODUCTS OFFERED 199
TABLE 156 ZIEHN IMAGING GMBH: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–SEPTEMBER 2025 200
TABLE 157 ZIEHN IMAGING GMBH: DEALS, JANUARY 2022–SEPTEMBER 2025 200
TABLE 158 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY OVERVIEW 201
TABLE 159 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: PRODUCTS OFFERED 202
TABLE 160 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: DEALS,
JANUARY 2022–SEPTEMBER 2025 202
TABLE 161 NEUSOFT MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW 203
TABLE 162 NEUSOFT MEDICAL SYSTEMS CO., LTD.: PRODUCTS OFFERED 203
TABLE 163 NEUSOFT MEDICAL SYSTEMS CO., LTD.: PRODUCT APPROVALS,
JANUARY 2022–SEPTEMBER 2025 204
TABLE 164 NEUSOFT MEDICAL SYSTEMS CO., LTD.: DEALS,
JANUARY 2022–SEPTEMBER 2025 204
TABLE 165 HITACHI HIGH-TECH CORPORATION: COMPANY OVERVIEW 205
TABLE 166 HITACHI HIGH-TECH CORPORATION: PRODUCTS OFFERED 206
TABLE 167 HITACHI HIGH-TECH CORPORATION: OTHER DEVELOPMENTS,
JANUARY 2022–SEPTEMBER 2025 207
TABLE 168 SHINVA MEDICAL INSTRUMENT CO., LTD.: COMPANY OVERVIEW 208
TABLE 169 SHINVA MEDICAL INSTRUMENT CO., LTD.: PRODUCTS OFFERED 209
TABLE 170 ACCURAY INCORPORATED: COMPANY OVERVIEW 210
TABLE 171 ACCURAY INCORPORATED: PRODUCTS OFFERED 211
TABLE 172 DMS HEALTH: COMPANY OVERVIEW 212
TABLE 173 NORTH STAR IMAGING INC.: COMPANY OVERVIEW 213
TABLE 174 FLUKE BIOMIDICAL: COMPANY OVERVIEW 213
TABLE 175 PRIZMED IMAGING: COMPANY OVERVIEW 214
TABLE 176 KONING HEALTH: COMPANY OVERVIEW 214
TABLE 177 PLANMECA OY: COMPANY OVERVIEW 215
TABLE 178 PINSENG HEALTHCARE: COMPANY OVERVIEW 215
TABLE 179 SCANLAB: COMPANY OVERVIEW 216
TABLE 180 ARINETA LTD.: COMPANY OVERVIEW 216
TABLE 181 RYOEI: COMPANY OVERVIEW 217
TABLE 182 BRAINLAB SE: COMPANY OVERVIEW 217
TABLE 183 RADIOLOGY ONCOLOGY SYSTEMS: COMPANY OVERVIEW 218
TABLE 184 BLOCK IMAGING, INC.: COMPANY OVERVIEW 218
LIST OF FIGURES
FIGURE 1 CT SIMULATORS MARKET SEGMENTATION & REGIONAL SCOPE 25
FIGURE 2 CT SIMULATORS MARKET: YEARS CONSIDERED 26
FIGURE 3 CT SIMULATORS MARKET: RESEARCH DATA 28
FIGURE 4 CT SIMULATORS MARKET: RESEARCH DESIGN 29
FIGURE 5 CT SIMULATORS MARKET: KEY SECONDARY SOURCES 30
FIGURE 6 CT SIMULATORS MARKET: KEY DATA FROM SECONDARY SOURCES 30
FIGURE 7 KEY PRIMARY SOURCES (DEMAND AND SUPPLY SIDES) IN
CT SIMULATORS MARKET 32
FIGURE 8 KEY SUPPLY- AND DEMAND-SIDE PARTICIPANTS IN CT SIMULATORS MARKET 32
FIGURE 9 CT SIMULATORS MARKET: BREAKDOWN OF PRIMARY INTERVIEWS (BY COMPANY TYPE, DESIGNATION, AND REGION) 33
FIGURE 10 CT SIMULATORS MARKET: KEY INSIGHTS FROM PRIMARY EXPERTS 34
FIGURE 11 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 35
FIGURE 12 CT SIMULATORS MARKET: COMPANY REVENUE ESTIMATION 36
FIGURE 13 CT SIMULATORS MARKET SIZE ESTIMATION METHODOLOGY (END USER AND REVENUE MAPPING-BASED) 37
FIGURE 14 CT SIMULATORS MARKET: TOP-DOWN APPROACH 38
FIGURE 15 GROWTH PROJECTIONS ON REVENUE IMPACT OF KEY MACROINDICATORS 39
FIGURE 16 CT SIMULATORS MARKET: DATA TRIANGULATION METHODOLOGY 41
FIGURE 17 CT SIMULATORS MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION) 43
FIGURE 18 CT SIMULATORS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 44
FIGURE 19 CT SIMULATORS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 45
FIGURE 20 CT SIMULATORS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 45
FIGURE 21 CT SIMULATORS MARKET: REGIONAL SNAPSHOT 46
FIGURE 22 INCREASED PROCEDURE CASELOAD AND ADOPTION OF ADAPTIVE RADIOTHERAPY TO GROW MARKET DEMAND 48
FIGURE 23 CHINA AND HOSPITALS TO COMMAND LARGEST MARKET SHARES IN 2024 49
FIGURE 24 CHINA TO REGISTER HIGHEST CAGR FROM 2025 TO 2030 50
FIGURE 25 CT SIMULATORS MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 51
FIGURE 26 CT SIMULATORS MARKET: TOP COMPANIES/APPLICANTS AND NUMBER OF PATENTS GRANTED, 2014–2024 60
FIGURE 27 KEY AI USE CASES IN CT SIMULATORS MARKET 63
FIGURE 28 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR
CT SIMULATORS, BY PRODUCT TYPE 75
FIGURE 29 KEY BUYING CRITERIA OF CT SIMULATORS, BY END USER 76
FIGURE 30 CT SIMULATORS MARKET: UNMET NEED ANALYSIS 78
FIGURE 31 CT SIMULATORS MARKET: PORTER’S FIVE FORCES ANALYSIS 79
FIGURE 32 CT SIMULATORS MARKET: VALUE CHAIN ANALYSIS 84
FIGURE 33 CT SIMULATORS MARKET: SUPPLY CHAIN ANALYSIS 85
FIGURE 34 CT SIMULATORS MARKET: ECOSYSTEM ANALYSIS 86
FIGURE 35 AVERAGE SELLING PRICE TREND OF CT SIMULATORS,
BY KEY PLAYER, 2022–2024 (USD) 88
FIGURE 36 AVERAGE SELLING PRICE TREND OF CT SIMULATORS,
BY REGION, 2022–2024 (USD) 89
FIGURE 37 IMPORT SCENARIO FOR HS CODE 9022.12, 2020–2024 (USD THOUSAND) 90
FIGURE 38 EXPORT SCENARIO FOR HS CODE 9022.12, 2020–2024 (USD THOUSAND) 91
FIGURE 39 CT SIMULATORS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 93
FIGURE 40 FUNDING AND NUMBER OF DEALS IN CT SIMULATORS MARKET,
2019–2023 (USD MILLION) 93
FIGURE 41 NUMBER OF DEALS IN CT SIMULATORS MARKET, BY KEY PLAYER, 2019–2023 94
FIGURE 42 VALUE OF DEALS IN CT SIMULATORS MARKET, BY KEY PLAYER, 2019–2023 (USD) 94
FIGURE 43 NORTH AMERICA: CT SIMULATORS MARKET SNAPSHOT 126
FIGURE 44 ASIA PACIFIC: CT SIMULATORS MARKET SNAPSHOT 137
FIGURE 45 REVENUE ANALYSIS OF KEY PLAYERS IN CT SIMULATORS MARKET,
2020–2024 (USD MILLION) 156
FIGURE 46 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CT SIMULATORS MARKET (2024) 157
FIGURE 47 MARKET RANKING OF KEY PLAYERS IN CT SIMULATORS MARKET (2024) 159
FIGURE 48 EV/EBITDA OF TOP THREE PLAYERS (2025) 159
FIGURE 49 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF TOP THREE PLAYERS (2025) 160
FIGURE 50 CT SIMULATORS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 161
FIGURE 51 CT SIMULATORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 163
FIGURE 52 CT SIMULATORS MARKET: COMPANY FOOTPRINT 164
FIGURE 53 CT SIMULATORS MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2024 169
FIGURE 54 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 176
FIGURE 55 PHILIPS HEALTHCARE: COMPANY SNAPSHOT 181
FIGURE 56 GE HEALTHCARE: COMPANY SNAPSHOT 185
FIGURE 57 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT 189
FIGURE 58 ELEKTA: COMPANY SNAPSHOT 193
FIGURE 59 FUJIFILM HEALTHCARE: COMPANY SNAPSHOT 197
FIGURE 60 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY SNAPSHOT 201
FIGURE 61 HITACHI HIGH-TECH CORPORATION: COMPANY SNAPSHOT 206
FIGURE 62 SHINVA MEDICAL INSTRUMENT CO., LTD.: COMPANY SNAPSHOT 208
FIGURE 63 ACCURAY INCORPORATED: COMPANY SNAPSHOT 211
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11